CDC meets to decide whether to resume Johnson & Johnson vaccinations in the U.S.

A CDC advisory committee will meet today to decide whether it is safe to resume public use of the single-dose COVID-19 Johnson and Johnson vaccine. It was paused last week to investigate reports of a rare and potentially deadly blood-clotting disorder in at least nine vaccine recipients. CBS News Medical Contributor Dr. David Agus discusses the latest on vaccine safety and what’s next for the JandJ vaccine. Source